Caroline Petersen writes, "Forging an emotional connection and bonding with potential customers is critical to converting prospects into lifelong clients, but doing so can be challenging in complex fields like medical devices, where products involve intricate scientific engineering and precise functionality. This is where the power of visual storytelling comes in." Learn more.
For this American Heart Month, Dr. Trotter is equipping Scribes with essential life-saving knowledge, providing CPR training and enabling them to make a meaningful impact during life or death situations. Read on.
Last year was one of the worst years ever for cyber attacks on healthcare organizations. According to John Riggi, national advisor for cybersecurity and risk for the American Hospital Association, the number of people affected by attacks broke records, with US federal data indicating that around 106 million people were impacted by a healthcare data breach, more than double when compared to 2022.
Moby Cutter™ is one of the safest surgical wire cutters on the market today! Their medical design team has over 35 years of experience performing surgical procedures in Hospitals, Emergency Rooms and Urgent Care Systems. It has been cleared for commercialization per FDA guidelines and sold as a prescription only (Rx) medical device. Dr. Stanley shares the advantages of the Moby Cutter.
Health systems continue to face ongoing pressures to reduce costs while maintaining quality patient care. With the average operating margin for hospitals at 0.84%, health systems are searching for ways to more effectively manage operating and capital budgets. However, gaps in data often hinder health systems by hiding cost burdens throughout the organization. These hidden costs limit health systems to finding one-time-savings without lasting relief from industry-wide pressures.
Jim Pearson advises October 29th is World Stroke Day (WSD) — an important day for the global stroke community to take action, educate, and focus on prevention. It is also a chance to deeply reflect on how we can continue to serve people who will suffer strokes in the future. For us leaders in the life sciences, WSD is a powerful reminder to ask ourselves how we can continue to innovate in order to decrease the lives lost and improve both clinical and economic outcomes. Over the past decade, we have built a company and team at NICO Corporation dedicated to bringing forth new innovations and, more importantly, scientific evidence in the deadliest type of stroke — hemorrhagic stroke. Read to learn more.
With cold and flu season approaching, more sick patients will be in hospitals in the coming months. Mr. Rizkallah discusses several challenges hospitals will face during this cold and flu season and how Honeywell's real-time health monitoring system can improve patient outcomes. Read on.
More than a year ago, the U.S. healthcare system marked a turning point with the passage of the No Surprises Act (NSA). Signed into federal law after extensive negotiation between health plan insurers and providers, the NSA took full effect at the start of 2022 to protect the rights of patients and health plan participants from receiving excessive balance bills for certain emergency services and from out-of-network providers at in-network facilities.
Collecting patient-reported outcome (PRO) data is an integral function of clinical research, providing the patient perspective that enriches the evaluation of treatment effectiveness. Historically, patient-reported outcomes measurement (PROM) was performed predominantly with paper-based assessments. However, over the past two decades, there has been a notable paradigm shift towards the electronic collection of data.
Cancer care continues to be one of the key cost drivers contributing to the $3.5 trillion healthcare costs in the United States, but minimally invasive treatments like Cryoablation Therapy may hold the promise of significantly reducing oncology related costs, while improving patient outcomes. It has the potential of reducing months of recovery time to only a few minutes, and the scope of cryoablation expands exponentially especially when utilized in concert with personalized precision medicine. Read on.
The growth of in-home care along with technology improvements like AI are shifting how medical device companies manage their inventory and final-mile deliveries. This, coupled by the increase of innovations like robotic-assisted surgeries, is creating a lasting impact on the medical devices supply chain. In fact, the healthcare third-party logistics (3PL) market is expected to grow at a compound annual growth rate of 7.6% from 2023 to 2030.
Watal writes, "Today, we see machines becoming more intelligent and capable than humans in many areas, from driving cars to diagnosing diseases. AI solves problems we cannot even approach, and it's getting better every day — but what does this mean for us?
As the President and CEO of Forma Medical, I am excited to share how our groundbreaking approach, known as OptimalHT, is set to revolutionize hammertoe treatment. Our mission at Forma Medical has always been clear: to enhance the lives of patients by providing innovative surgical solutions. Today, I want to take you on a journey through the challenges of hammertoe deformities, the birth of OptimalHT, its key benefits, and our commitment to advancing surgery.
Holt writes, "Avian flu is a global crisis, and not just for the poultry industry. There are serious potential implications for human health as well. But, let’s start with agriculture. Some strains of avian flu can be highly pathogenic. Once a single bird shows symptoms the clock starts ticking — it’s not unusual for an entire flock of tens of thousands of birds to die within two to three days."
Watal writes, "Less than 12 months ago, with the debut of AI-powered ChatGPT, the true power of AI hit the mainstream. Since then, it has established an unshakeable belief in everyone’s minds that artificial intelligence is here to stay and will forever alter a number of industries." What do you think? Read on.
This article takes a closer look at the key benefits of automation and technology in pharmaceutical manufacturing and how Medivant Healthcare harnesses these solutions to drive progress across our production facilities. Read what Viraj Gandhi has to say.
Shawn Murphy writes, "The Limb Loss and Preservation Registry (LLPR) represents a pivotal development in patient care. It stands as the first collaborative database that unites hospital and health systems, provider organizations such as Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs) and orthotic/prosthetic (O&P) practices, focusing on both upper and lower extremity acquired and congenital limb differences, as well as limb preservation populations. This collective effort has the potential to drive substantial advancements in patient outcomes, treatment effectiveness and care quality." Read to learn more.
Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read on.